-
Marijuana's new drug classification could unlock long-delayed medical research
The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered. -
CCC vote moves Massachusetts a step closer to 'new world' of cannabis cafes
On-site marijuana consumption will be allowed at licensed businesses, under regulations approved Thursday. -
O’Brien returns to CCC, social consumption rules delayed
Social consumption was part of the 2016 ballot law that legalized marijuana here but has not yet become a reality. -
Judge denies bid to block fired leader’s return to cannabis commission
Treasurer Deb Goldberg hasn’t decided on a “next step,” according to spokesman. -
As cannabis commission saga takes another twist, industry insiders long for closure
Business leaders say the public back-and-forth is bad for the industry. -
Court rules fired CCC Chair Shannon O'Brien must be reinstated
O'Brien was wrongfully terminated and is entitled to back pay, a judge ruled after two years of legal drama. -
‘Corruption’ or ‘just cheap’? Mixed reactions to sheriff’s extortion charges
Community reacts to news of charges against the Suffolk County sheriff. -
Early cannabis users show lower brain coherence and cognitive challenges
McLean Hospital's Dr. Staci Gruber has been researching how early marijuana use may lead to difficulty with decision-making and executive functioning. -
Cannabis competitor flowering in convenience stores
Reformers urge lawmakers to force regulation of hemp-based products. -
Labs warn mold contamination is more widespread than Cannabis Control Commission has let on
They say they've lost business due to lab shopping, and consumers are at risk of using contaminated products.
